5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.21▼ | 1.21▼ | 1.21▼ | 1.17▲ | 1.14▲ |
MA10 | 1.20▼ | 1.20▼ | 1.20▼ | 1.15▲ | 1.31▼ |
MA20 | 1.21▼ | 1.19▲ | 1.19▲ | 1.15▲ | 1.30▼ |
MA50 | 1.18▲ | 1.17▲ | 1.15▲ | 1.33▼ | 1.82▼ |
MA100 | 1.20▲ | 1.14▲ | 1.13▲ | 1.30▼ | 3.05▼ |
MA200 | 1.15▲ | 1.14▲ | 1.17▲ | 1.57▼ | 4.79▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | 0.001▲ | 0.000▲ | 0.020▲ | 0.011▲ |
RSI | 51.377▲ | 54.792▲ | 55.625▲ | 49.720▼ | 42.445▼ |
STOCH | 53.333 | 50.079 | 62.143 | 55.897 | 13.157▼ |
WILL %R | -66.667 | -57.143 | -40.000 | -43.333 | -81.006▼ |
CCI | -49.813 | 0.658 | 35.019 | 129.282▲ | -66.566 |
Thursday, August 14, 2025 10:08 AM
Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC) has officially entered the most critical phase of its development journey—pursuing a potential registration-enabling trial in first-line metastatic ...
|
Thursday, August 14, 2025 05:23 AM
Q2 2025 Earnings Call Transcript August 13, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.24. Operator: Greetings. Welcome to PDS ...
|
Wednesday, August 13, 2025 07:21 AM
No revenue reported as development-stage programs advanced in key clinical trials. These 10 stocks could mint the next wave of millionaires › PDS Biotechnology (NASDAQ:PDSB), a clinical-stage ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 1.22 | 1.25 | 1.18 | 1.19 | 340,707 |
14/08/25 | 1.16 | 1.21 | 1.1287 | 1.20 | 305,341 |
13/08/25 | 1.26 | 1.32 | 1.16 | 1.16 | 800,846 |
12/08/25 | 1.10 | 1.23 | 1.08 | 1.23 | 638,259 |
11/08/25 | 1.11 | 1.11 | 1.06 | 1.08 | 323,695 |
08/08/25 | 1.12 | 1.17 | 1.08 | 1.11 | 248,334 |
07/08/25 | 1.10 | 1.12 | 1.06 | 1.12 | 363,182 |
06/08/25 | 1.13 | 1.132 | 1.08 | 1.11 | 257,437 |
05/08/25 | 1.15 | 1.15 | 1.11 | 1.13 | 202,059 |
04/08/25 | 1.10 | 1.12 | 1.0796 | 1.12 | 212,909 |
|
|
||||
|
|
||||
|
|